PolyXen 平台 :PolyXen是蛋白质和肽药物输送的使能平台技术。它使用生物聚合物聚唾液酸(PSA)来延长药物的半衰期,并可能提高治疗肽和蛋白质的稳定性。附着部位和PSA链的长度都可以通过改变分子的表观流体力学半径来影...查看全文
牛股小红书2022-04-28 13:48
$Xenetic Biosciences(XBIO)$ 与CLS Therapeutics签署了独家许可和再许可协议,以开发其基于DNA酶的介入性肿瘤学平台,旨在改善现有治疗,包括免疫疗法。
根据协议,Xenetic拥有CLS知识产权的独家许可证,用于在癌症中使用DNA酶,包括DNA酶与标准疗法(包括化疗、放疗和检查点抑制剂)的系统联...查看全文
$Xenetic Biosciences(XBIO)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-09-04 AccNo: 0001535610-19-000095 Size: 13 KB 网页链接
$Xenetic Biosciences(XBIO)$ 8-K - Current report Filed: 2019-08-15 AccNo: 0001683168-19-002648 Size: 59 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Xenetic Biosciences(XBIO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-14 AccNo: 0001683168-19-002639 Size: 1 MB 网页链接
$Xenetic Biosciences(XBIO)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-08-07 AccNo: 0001104659-19-044521 Size: 103 KB 网页链接
$Xenetic Biosciences(XBIO)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-07-29 AccNo: 0001193125-19-204659 Size: 127 KB 网页链接
$Xenetic Biosciences(XBIO)$ SC 13D - General statement of acquisition of beneficial ownership Filed: 2019-07-29 AccNo: 0000944809-19-000050 Size: 127 KB 网页链接
$Xenetic Biosciences(XBIO)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-07-25 AccNo: 0001387131-19-005343 Size: 127 KB 网页链接
$Xenetic Biosciences(XBIO)$ 8-A12B - Registration of securities [Section 12(b)] Filed: 2019-07-22 AccNo: 0001683168-19-002273 Size: 21 KB 网页链接
$Xenetic Biosciences(XBIO)$ CERT - Filed: 2019-07-22 AccNo: 0001354457-19-000362 Size: 161 KB 网页链接
$Xenetic Biosciences(XBIO)$ 8-K - Current report Filed: 2019-07-22 AccNo: 0001683168-19-002278 Size: 956 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 5.02: Departure of Directors or Certain Officers; Election of...